Search results for: health insurance

What’s in the New Biden Plan to Reduce U.S. Drug Prices?

Ahmed Aboulenein | November 4, 2021

WASHINGTON (Reuters)—U.S. President Joe Biden and his fellow Democrats promised voters sweeping drug price reform in their signature social spending bill but agreed to move ahead with a far less ambitious proposal after facing opposition in Congress. The plan could still fail as hurdles remain to approving the broader spending package, known as “Build Back…

Tips for Transitioning Patients from Pediatric to Adult Rheumatology Care

Sarah D. Bayefsky, MD, Kimberly DeQuattro, MD, & Rebecca E. Sadun, MD, PhD | October 14, 2021

Approximately 50% of young adult patients with childhood-onset rheumatic diseases become lost to follow-up within the first year of transferring to adult rheumatology care, mirroring the statistics of other subspecialties.1,2 One of the challenges cited most consistently by young adult patients and their families relates to differences between rheumatology care delivery in the pediatric and…

What’s in the New COVID-19 Relief Package?

From the College | March 10, 2021

The U.S. House of Representatives passed the American Rescue Plan Act of 2021 (H.R. 1319) on March 10, 2021, after Senate passage on March 6. President Biden signed the bill into law on March 11. Following is the ACR’s summary of the most impactful provisions of this third COVID-19 relief package. Fighting COVID-19 $160 billion…

What Happens When Patients Have Access to Their Clinician’s Notes?

Ruth Jessen Hickman, MD | February 18, 2021

Navigating the healthcare system and its processes can seem overwhelming to patients. If patients understand why their clinician recommended something, know how and when to take medications, and why they shouldn’t skip a dose—or 10—they may not feel so out of control. Sharing examination notes with patients can be helpful to many patients who struggle…

Telerheumatology: What’s Next?

Susan Bernstein | December 17, 2020

In an ACR Convergence session, two rheumatologists discussed how COVID-19 changed the use of telemedicine, how payers reacted and which changes are likely permanent and which are likely to be temporary.

Patients Demonstrated Good Medication Adherence While Taking Biosimilar Treatment

Michele B. Kaufman, PharmD, BCGP | December 7, 2020

Researchers found half of patients taking the biosimilar infliximab-dyyb (Inflectra) remained highly adherent to medication use after 12 months.

How to Terminate a Patient Relationship

Steven M. Harris, Esq. | November 12, 2020

The success of a physician-patient relationship encompasses several important factors, including mutual respect, trust and effective communication. But what can be done when this relationship becomes adversarial and communication breaks down? The American Medical Association has historically pointed out that poor physician-patient communication is directly related to malpractice or discrimination lawsuits. When providers end a…

Pediatric Care, Disparity Awareness Among Rheumatology Research Foundation-Funded Studies Underway

Carina Stanton | November 10, 2020

Investigators are tackling rheumatology practice challenges, assessing what drives career choices in pediatric rheumatology, improving fellowship training and more—all with the support of the Rheumatology Research Foundation.

ACR Leads Resolution to Address Copay Accumulator Policies at AMA House of Delegates Meeting

From the College | November 6, 2020

If passed, the ACR-authored resolution will direct the AMA to advocate for copay accumulator bans at state and federal levels. Several other specialties and state medical associations have joined the resolution as cosponsors.